Adoption of audited result and recommend dividend
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Crestchem Ltd approved the audited standalone financial results for Q4 and the full financial year ended March 31, 2025. Revenue from operations grew about 18% YoY to Rs 2,507.72 lacs (FY24: Rs 2,125.62 lacs), while Q4 revenue jumped over 50% to Rs 737.27 lacs. Profit after tax rose approximately 27% to Rs 272.65 lacs (FY24: Rs 214.63 lacs), with basic EPS of Rs 9.09 vs Rs 7.15. The Board recommended a final dividend of Rs 1.00 per share (10%) on a face value of Rs 10, subject to shareholder approval at the AGM. The statutory auditor issued an unmodified (clean) opinion on the results. The company remains debt-free with zero borrowings and generated positive operating cash flow of Rs 166.17 lacs (FY24: Rs 34.79 lacs). The Board also appointed Mrs. Rinkal M Jasani as a non-executive woman Independent Director and M/s. Mehul Raval & Associates as Secretarial Auditor for a 5-year term.
Positive for shareholders: double-digit profit growth, clean audit opinion, debt-free balance sheet, and a 10% dividend signal healthy fundamentals and management confidence, though the stock is a small-cap and the dividend yield is modest.